Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04181307 · ClinicalTrials.gov registry record · NA
A Randomized Trial of a BE-EHR Module to Guide the Care of Older Adults With Diabetes
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 7,630
- Enrollment target
NCT04181307: Completed NA study, sponsored by NYU Langone Health.
NCT04181307 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 7,630 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (444% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04181307, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 7,630 participants
- Enrollment target
Study Summary
This RCT will test a new electronic health record module to improve guideline-compliant care of older adults with diabetes. The module incorporates effective behavioral economics (BE) principles to improve the degree to which care of older adults is compliant with Choosing Wisely (CW) guidelines; this generally involves less aggressive targets for HbA1c, and reductions of medications other than metformin. The implementation of the module is triggered by patient scheduling and medication prescribing in EPIC. The BE principles include suggesting alternatives to medications, requiring justification, setting of appropriate default order sets, and incorporation of anchoring and checklists to guide behavior.
Primary Outcome
In order to evaluate Choosing Wisely (CW) compliance status, the BE-EHR algorithm will capture information on demographics, diagnoses in the patient's problem list, prescription history, and relevant lab results (i.e. allergies and blood glucose (HbA1c)) The study team members will not collect this information directly; data will be collected in NYULH's EHR system, EPIC, and an EPIC Reporting analyst will extract the relevant parameters from the EHR into a report. The study team members only rec
Interventions
- BEHAVIORAL BE-EHR module
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,630 participants |
| Start Date | 2020-12-01 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
What the finished NCT04181307 record still lists
NCT04181307 is an interventional study that assigns participants to a tested intervention. Its 7,630 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (444% higher).
The record links to 0 conditions, and to 1 intervention - of which BE-EHR module is the first listed.
NCT04181307 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04181307 about?
NCT04181307 is a clinical study titled "A Randomized Trial of a BE-EHR Module to Guide the Care of Older Adults With Diabetes". This RCT will test a new electronic health record module to improve guideline-compliant care of older adults with diabetes. The module incorporates effective behavioral economics (BE) principles to improve the degree to which care of older adults is compliant with Choosing Wisely (CW) guidelines; th...
What is the current status of trial NCT04181307?
This trial is currently completed. It is a NA study. The enrollment target is 7,630 participants. The study started on 2020-12-01. Estimated completion is 2022-07-01.
What interventions are being tested in trial NCT04181307?
The interventions under investigation include: BE-EHR module (BEHAVIORAL).
Who is sponsoring clinical trial NCT04181307?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04181307's enrollment target sits among peer trials
7,630 20th of 2000 higher than 1,981 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06560398 · 7,649 participants · NA
Working Through Outreach, Navigation and Digital Enabled Referral and Recruitment Strategies (ACT WONDER²S)
- NCT03848312 · 7,600 participants · Phase 3
Preventing Alzheimer's With Cognitive Training
- NCT00439049 · 7,500 participants
Substance Abuse Pre-Treatment Screening Study
- NCT04809740 · 7,500 participants · NA
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI